REBLOZYL
Celgene Corporation
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87329959 |
| Registration Number | 5321484 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Camille M. Miller |
| Attorney Docket Number | CELG-1684US/ |
| Law Office Assigned | N40 |
| Employee Name | ADEMI, XHENETA |
Timeline
| 2017-02-09 | Application Filed |
| 2017-08-15 | Published for Opposition |
| 2017-10-31 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-10-31 | Status: Live/Registered |
| 2017-10-31 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Celgene Corporation |
| Address | 86 Morris Avenue Summit DE 07901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-02-13 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-02-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-04-14 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-04-18 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-04-18 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-04-18 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-04-21 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-05-15 | 8 ALIE A:Allowance for Publication |
| ASSIGNED TO LIE | 2017-05-17 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-05-25 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-05-25 | 11 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2017-06-09 | 12 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-06-09 | 13 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-06-09 | 14 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-06-14 | 15 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-06-26 | 16 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-06-26 | 17 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-06-27 | 18 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-07-26 | 19 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-08-15 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-08-15 | 21 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-10-31 | 22 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-01-05 | 23 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-01-05 | 24 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-01-05 | 25 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-01-05 | 26 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-01-05 | 27 CHAN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-10-31 | 28 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2023-10-03 | 29 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2024-03-28 | 30 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2024-03-28 | 31 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2024-03-28 | 32 NA85 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REBLOZYL 90033523 not registered Live/Pending |
Celgene Corporation 2020-07-02 |
 REBLOZYL 88822744 not registered Live/Pending |
Celgene Corporation 2020-03-05 |
 REBLOZYL 87329959 5321484 Live/Registered |
Celgene Corporation 2017-02-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 